Surveillance of Dutch Patients With Li-Fraumeni Syndrome: The LiFe-Guard Study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 28772294.
- Also identified by DOI 10.1001/jamaoncol.2017.1346 and PMC identifier 5824278.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study of patients with Li-Fraumeni syndrome assesses the diagnostic yield and false-positive rate of an annual surveillance program including whole-body magnetic resonance imaging in patients identified as carriers of <i>TP53</i> gene mutations.
Medical subject headings
- Germ-Line Mutation
- Li-Fraumeni Syndrome
- Tumor Suppressor Protein p53